This year, due to COVID, we will be holding our annual partners' meeting virtually, While we will miss seeing many of you in person, we look forward to this format enabling even more partners - and numerous representatives from partner organizations - to be able to participate.
Africa’s first COVID cases were diagnosed in mid-February 2020. One year on, the African Leaders Malaria Alliance, Comic Relief and GSK will host an online event series exploring how partners across the Africa region have continued to safeguard progress in the fight against malaria despite the global pandemic.
The event will bring together leaders from government, civil society, regional organisations and the private sector to explore what is working in the fight against malaria across Africa.
Under the RBM Partnership’s strategic objective 1, “Keeping malaria high on the political agenda”, the Advocacy and Resource Mobilisation Partner Committee (ARMPC) works towards engaging existing parliamentary groups on malaria, as well as supporting the creation and establishment of new parliamentary interest groups in donor and endemic countries that may be specific to malaria or include other health areas, such as NTDs or vector-borne diseases.
The RBM Partnership’s Advocacy and Resource Mobilisation Partner Committee (ARMPC) includes a dedicated workstream on Innovation and Access (I&A) which aims to sustain and increase cross-sectoral support for investing in malaria innovations, creating demand for the most effective innovations, and supporting scale-up of innovations for the populations most in need of accessing them.
The RBM Partnership Strategic Plan 2021-2025 outlines the RBM Partnership to End Malaria’s strategic priorities over the next five years. It considers the current landscape – including recent progress made towards malaria elimination and challenges such as COVID-19 - as well as longer-term milestones, including the existing malaria targets set for 2025 and 2030.
The supplier will be responsible for the following objectives:
The RBM Partnership to End Malaria is the global platform for coordinated action against malaria. It mobilizes for action and resources and forges consensus among partners. The Partnership is comprised of more than 500 partners, including malaria endemic countries, their bilateral and multilateral development partners, the private sector, nongovernmental and community-based organizations, foundations, and research and academic institutions. For more info check the RBM website: www.endmalaria.org.
While the COVID-19 pandemic persists and continues to take a toll on health systems worldwide, it is important to recognize the remarkable efforts made at country, regional, and international levels to mitigate its impact on malaria. The RBM Partnership recently published a new brief with the best practices observed and applied in the past year to mitigate the effect of COVID-19 on malaria, highlighting practices such as extensive advocacy, extraordinary collaboration, as well as timely guidance and technical assistance by malaria partners.